Compositions and methods of muscle specific kinase chimeric autoantibody receptor cells
US11905321B2 · kind B2 · utility
0Cited by
20References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2019 |
| Grant date | Feb 20, 2024 |
| Priority date | — |
| Expiry date | Jun 4, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention includes a chimeric autoantibody receptor (CAAR) specific for anti-muscle-specific kinase (MuSK) B cell receptor (BCR), compositions comprising the CAAR, polynucleotides encoding the CAAR, vectors comprising a polynucleotide encoding the CAAR, and recombinant cells comprising the CAAR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.